ID

38216

Descripción

Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02472353

Link

https://clinicaltrials.gov/show/NCT02472353

Palabras clave

  1. 28/9/19 28/9/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

28 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT02472353

Eligibility Breast Cancer NCT02472353

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
breast cancer requiring neoadjuvant or adjuvant therapy with doxorubicin
Descripción

Breast Carcinoma | Requirement Doxorubicin Neoadjuvant Therapy | Requirement Doxorubicin Adjuvant therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0013089
UMLS CUI [2,3]
C0600558
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0013089
UMLS CUI [3,3]
C0677850
complete metabolic panel demonstrating adequate organ functions as defined by the following: ast less than 2.5 times uln; alt less than 2.5 times uln; alkaline phosphatase less than 2.5 times uln; serum creatinine less than 1.5 mg/dl; serum bilirubin less than uln
Descripción

Metabolic Panel Complete | Organ function | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Creatinine measurement, serum | Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4281808
UMLS CUI [1,2]
C0205197
UMLS CUI [2]
C0678852
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
UMLS CUI [5]
C0201850
UMLS CUI [6]
C0201976
UMLS CUI [7]
C1278039
ecog performance status of 0 or 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
age greater than or equal to 21 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known diabetes
Descripción

Diabetes Mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011849
history of cardiac arrhythmias or symptomatic cardiac disease
Descripción

Cardiac Arrhythmia | Heart Disease Symptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003811
UMLS CUI [2,1]
C0018799
UMLS CUI [2,2]
C0231220
currently taking antiarrhythmic medications, beta-blockers, or other rate controlling cardiac medications
Descripción

Anti-Arrhythmia Agents | Adrenergic beta-1 Receptor Antagonists | Pharmaceutical Preparations Heart rate Control

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003195
UMLS CUI [2]
C0304516
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0018810
UMLS CUI [3,3]
C2587213
currently taking metformin and/or sulfonylureas
Descripción

Metformin | Sulfonylureas

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0025598
UMLS CUI [2]
C0038766
known hypersensitivity or intolerance to metformin
Descripción

Metformin allergy | intolerance to Metformin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0571648
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0025598
baseline ejection fraction of less than 50% measured by echocardiogram
Descripción

Cardiac ejection fraction Echocardiography

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0232174
UMLS CUI [1,2]
C0013516
known hypersensitivity to contrast used during echocardiogram
Descripción

Contrast media allergy | Contrast echocardiography Related

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0570562
UMLS CUI [2,1]
C0013518
UMLS CUI [2,2]
C0439849
risk factors associated with increased risk of metformin-associated lactic acidosis (e.g. congestive heard failure, history of acidosis, habitual intake of 3 or more alcoholic beverages per day)
Descripción

Risk factors | Risk Lactic Acidosis Metformin Induced | Congestive heart failure | Acidosis | Alcoholic Beverages U/day

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0035648
UMLS CUI [2,1]
C0035647
UMLS CUI [2,2]
C0001125
UMLS CUI [2,3]
C0025598
UMLS CUI [2,4]
C0205263
UMLS CUI [3]
C0018802
UMLS CUI [4]
C0001122
UMLS CUI [5,1]
C0001967
UMLS CUI [5,2]
C0456683
pregnant or breast feeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Similar models

Eligibility Breast Cancer NCT02472353

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma | Requirement Doxorubicin Neoadjuvant Therapy | Requirement Doxorubicin Adjuvant therapy
Item
breast cancer requiring neoadjuvant or adjuvant therapy with doxorubicin
boolean
C0678222 (UMLS CUI [1])
C1514873 (UMLS CUI [2,1])
C0013089 (UMLS CUI [2,2])
C0600558 (UMLS CUI [2,3])
C1514873 (UMLS CUI [3,1])
C0013089 (UMLS CUI [3,2])
C0677850 (UMLS CUI [3,3])
Metabolic Panel Complete | Organ function | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Creatinine measurement, serum | Serum total bilirubin measurement
Item
complete metabolic panel demonstrating adequate organ functions as defined by the following: ast less than 2.5 times uln; alt less than 2.5 times uln; alkaline phosphatase less than 2.5 times uln; serum creatinine less than 1.5 mg/dl; serum bilirubin less than uln
boolean
C4281808 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0678852 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
C1278039 (UMLS CUI [7])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Age
Item
age greater than or equal to 21 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus
Item
known diabetes
boolean
C0011849 (UMLS CUI [1])
Cardiac Arrhythmia | Heart Disease Symptomatic
Item
history of cardiac arrhythmias or symptomatic cardiac disease
boolean
C0003811 (UMLS CUI [1])
C0018799 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
Anti-Arrhythmia Agents | Adrenergic beta-1 Receptor Antagonists | Pharmaceutical Preparations Heart rate Control
Item
currently taking antiarrhythmic medications, beta-blockers, or other rate controlling cardiac medications
boolean
C0003195 (UMLS CUI [1])
C0304516 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C0018810 (UMLS CUI [3,2])
C2587213 (UMLS CUI [3,3])
Metformin | Sulfonylureas
Item
currently taking metformin and/or sulfonylureas
boolean
C0025598 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
Metformin allergy | intolerance to Metformin
Item
known hypersensitivity or intolerance to metformin
boolean
C0571648 (UMLS CUI [1])
C1744706 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Cardiac ejection fraction Echocardiography
Item
baseline ejection fraction of less than 50% measured by echocardiogram
boolean
C0232174 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
Contrast media allergy | Contrast echocardiography Related
Item
known hypersensitivity to contrast used during echocardiogram
boolean
C0570562 (UMLS CUI [1])
C0013518 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
Risk factors | Risk Lactic Acidosis Metformin Induced | Congestive heart failure | Acidosis | Alcoholic Beverages U/day
Item
risk factors associated with increased risk of metformin-associated lactic acidosis (e.g. congestive heard failure, history of acidosis, habitual intake of 3 or more alcoholic beverages per day)
boolean
C0035648 (UMLS CUI [1])
C0035647 (UMLS CUI [2,1])
C0001125 (UMLS CUI [2,2])
C0025598 (UMLS CUI [2,3])
C0205263 (UMLS CUI [2,4])
C0018802 (UMLS CUI [3])
C0001122 (UMLS CUI [4])
C0001967 (UMLS CUI [5,1])
C0456683 (UMLS CUI [5,2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial